임상 레이더 AI | ||
|---|---|---|
임상시험 NCT06402578은(는) 제2형 당뇨병에 대해 대상자모집전 상태입니다. 모든 세부 정보를 보려면 임상시험 레이더 카드 뷰와 AI 발견 도구를 확인하거나 여기에서 무엇이든 물어보세요. | ||
하나의 임상시험이 필터 기준과 일치합니다.
카드 뷰
A 12-week Digital Physical Activity Programme, With or Without Physical Education Support for Type 2 Diabetes Patients. 60
임상시험 세부 정보는 주로 영어로 제공됩니다. 하지만 임상 레이더 AI가 도와드릴 수 있습니다! '임상시험 설명'를 클릭하여 선택한 언어로 임상시험 정보를 확인하고, 이에 대해 AI와 논의해 보세요.
임상시험 NCT06402578은(는) 제2형 당뇨병에 대해 알아보는 중재연구입니다. 현재 상태는 대상자모집전이며, 2024년 6월 1일부터 참여 신청이 가능합니다. 60명의 참여자를 모집할 예정입니다. Queen Margaret University이(가) 진행하는 이 연구는 2025년 9월 1일까지 진행될 예정입니다. ClinicalTrials.gov의 가장 최근 정보는 2024년 5월 7일에 갱신되었습니다.
간단한 개요
Investigation into the effects of a 12-week digital physical activity programme, with or without physical education support on blood glucose control in patients with T2DM using HbA1c testing.
상세한 설명
Primary objective: investigate the effects of a 12-week digital physical activity programme, with or without physical education support on blood glucose control in patients with T2DM using HbA1c testing. Secondary objective: evaluate the effects on Cholesterol (ratio of High Density Lipids to Low Density Lipids), Resting Heart Rate, and Body Mass Index after a 12 week physical activity programme. Monitor step counts ...더 보기
공식 제목
A Feasibility Randomised Controlled Trial to Investigate the Effects of a 12-week Digital Physical Activity Programme, With or Without Physical Education Support, on Blood Glucose Control in Patients With Type 2 Diabetes Mellitus
질환명
제2형 당뇨병기타 연구 식별자
- QMU-IRAS ID: 327162
NCT 번호
실제 연구 시작일
2024-06
최신 업데이트 게시
2024-05-07
예상 연구 완료일
2025-09
계획된 등록 인원
60
연구종류
중재연구
단계/상
해당 없음
상태
대상자모집전
키워드
HbA1c
Cholesterol
Resting Heart Rate
Cholesterol
Resting Heart Rate
주요 목적
기초과학
설계 할당
무작위배정
중재 모델
평행설계
맹검 (마스킹)
단일맹검
시험군 / 개입
| 참가자 그룹/시험군 | 개입/치료 |
|---|---|
비개입Control Group, Control Group, will be issued with a smartwatch that is paired with a freely accessible App called Alexia® to record their PA. They will be asked to carry on with their daily activity and to record when they do any of their own physical activities that they do themselves routinely on an everyday basis during the 12 week study. They will not receive a 12 week PA programme. | 해당 없음 |
실험적Intervention 1 Intervention 1, will be provided with a 12 week PA programme and asked to record their PA while they follow the programme during the 12 week study. | HbA1c testing Bloods will be take pre and post 12 week intervention. |
실험적Intervention 2 Intervention 2, will also be provided with the same 12 week PA program and asked to record their PA while they follow the programme during the 12 week study. The participants in this group will also get support from a physical activity professional (PAP) who will be monitoring their 12 week journey. The PAP will be prompting the participant with weekly information as to why they are doing these exercises as well as s...더 보기 | HbA1c testing Bloods will be take pre and post 12 week intervention. |
주요결과변수
이차결과변수
| 결과변수 | 측정값 설명 | 시간 범위 |
|---|---|---|
HbA1c testing | blood will be take pre and post trial. | 12 weeks |
| 결과변수 | 측정값 설명 | 시간 범위 |
|---|---|---|
Cholesterol ratio testing | blood will be take pre and post trial. | 12 weeks |
참여 도우미
적격성 기준
연령대
성인, 노인
최소 연령
18 Years
참여 가능한 성별
전체
건강한 참가자 허용
네
- A diagnosis of T2DM in the last 3 years.
- Age 18+ years.
- Uses the English language as a primary or secondary language with the ability to read and write.
- Lives in the United Kingdom.
- Has no medical reason preventing participation in regular physical activity.
- Has a SMART phone with access to the internet.
- Physical inability to participate in 12 weeks of physical activity.
- Cardiac or cardiovascular surgery in the past 6 months.
- Musculoskeletal issues that could be aggravated whilst participating in regular physical activity.
- Presently participating in a weight loss programme.
- Unable to commit to the 12-week feasibility study.
Queen Margaret University연구 책임자
Phil Calvert, 책임연구자, Principal Investigator, Queen Margaret University
연구 대표 연락처
연락처: Philip Calvert, MSc, 0131 474 0000, [email protected]
연락처: Derek Santos, PHD, 0131 474 0000, [email protected]
1 1개국에 임상시험 장소
Musselburgh
Queen Margret University Edinburgh, Edinburgh, Musselburgh, EH21 6UU, United Kingdom